Patent Law Weblog
recent posts
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
- Federal Circuit Refuses to Switch District Court’s Finding for Nintendo
- Supreme Court to Resolve Dispute Over Marketing of “Skinny Labeled” Generics
about
Month: January 2014
-
By Donald Zuhn — Last month, the U.S. Food and Drug Administration (FDA) announced that the agency approved 27 new drugs and biological products in 2013. According to the FDA release, the 27 new molecular entities (NMEs) that were approved last year include: The number of new drugs approved in 2013 fell by almost a…
-
By Donald Zuhn — Last month, the National Academy of Inventors (NAI) and the Intellectual Property Owners Association (IPO) published a list of the top 100 worldwide universities that received the most U.S. utility patents in 2012. The groups did not provide a detailed discussion regarding the compilation of the list, stating only that the…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Cephalon Inc. v. Sandoz Inc.1:13-cv-02104; filed December 31, 2013 in the District Court of Delaware Cephalon Inc. v. Hospira Inc.1:13-cv-02094; filed December 26, 2013 in the District Court of Delaware Cephalon Inc. v. Accord…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "After Actavis: FTC Update" on January 9, 2014 beginning at 2:00 pm (ET). A panel consisting of Steven Lee of Kenyon & Kenyon LLP, Michael Perry of the Health Care Division of the Bureau of Competition at the Federal Trade Commission, and Bruce…
-
By Donald Zuhn — Reflecting upon the events of the past twelve months, Patent Docs presents its seventh annual list of top biotech/pharma patent stories. For 2013, we identified fourteen stories that were covered on Patent Docs last year that we believe had (or are likely to have) the greatest impact on biotech/pharma patent practitioners…
-
January 8-12, 2014 – National CLE Conference (Law Education Institute, Inc.) – Vail, CO January 16, 2014 – "Provisional Patent Applications: Preserving IP Rights in First-to-File System — Assessing Whether to Use — and Strategies for Leveraging — Provisional Applications Under the New Patent Regime" (Strafford) – 1:00 to 2:30 pm (EST) January 21, 2014…
-
Momentum will be holding an IP Counsel Exchange for Biosimilar Applicants & Sponsors January 23-24, 2014 in New York, NY. Developed to provide a forum for IP counsel within the pharmaceutical, biopharmaceutical and biotechnology space, the IP Counsel Biosimilars Exchange will focus on providing participants with best practices and proven strategies for best positioning biosimilar/biobetter…
-
American Conference Institute (ACI) will be holding a conference on Pharmaceutical and Biotechnology Patent Life Cycles and Portfolio Strategies on February 26-27, 2014 in New York, NY. ACI faculty will help attendees: • Apply second generation small molecule patent portfolio management strategies to large molecule patents;• Understand how safe harbor and 272(e)(1) controversies under Classen…
-
By Donald Zuhn — Reflecting upon the events of the past twelve months, Patent Docs presents its seventh annual list of top biotech/pharma patent stories. For 2013, we identified fourteen stories that were covered on Patent Docs last year that we believe had (or are likely to have) the greatest impact on biotech/pharma patent practitioners…
-
By Donald Zuhn — Reflecting upon the events of the past twelve months, Patent Docs presents its seventh annual list of top biotech/pharma patent stories. For 2013, we identified fourteen stories that were covered on Patent Docs last year that we believe had (or are likely to have) the greatest impact on biotech/pharma patent practitioners…
Patent Docs 